Unstable angina pectoris
Conditions
Interventions
Sponsors
Guanganmen Hospital, Chinese Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Conforms to the diagnostic criteria of unstable angina pectoris in the guidelines for the diagnosis and treatment of unstable angina pectoris and non-st-segment elevation myocardial infarction published by the Chinese society of cardiovascular diseases. The diagnostic criteria of TCM syndromes are consistent with phlegm and blood stasis obstruction syndrome; (2) Patients with coronary heart disease confirmed by coronary angiography (1 or more major coronary artery stenosis degree >=50%); (3) Aged 35-75 years old; (4) Participate voluntarily in this clinical study and sign the informed consent form. Subjects should insist on taking the medicine for 4 weeks, complete the scale and test before and after treatment. A fixed contact way to complete the follow-up work is also requisite.
Exclusion criteria
Exclusion criteria: 1. Those who have been confirmed to have chest pain caused by stable angina pectoris, acute myocardial infarction, aortic dissection, other congenital heart disease, valvular disease, severe neurosis, etc .; 2. Poorly controlled hypertension (systolic blood pressure >=160mmHg or diastolic blood pressure >=100mmHg), severe cardiopulmonary dysfunction (heart function level III or IV); 3. Chest tightness and chest pain caused by arrhythmia; 4. Acute stage of cerebral infarction; 5. Patients with severe primary diseases such as liver, kidney, hematopoietic system, liver function ALT or AST value> 1.5 times the upper limit of normal value, those with abnormal renal function; 6. Those with acute infection within the last 2 weeks; 7. Combine with other serious diseases who must be treated (such as blood diseases, tumors, etc.); 8. Diabetes does not meet the general control standards, or more serious diabetes complications occur; 9. Women who are pregnant or breastfeeding; 10. Those with allergies or allergies to the test drug ingredients. In addition: 1) patients who are participating in other clinical trials or patients whose clinical trials are finished less than one month; 2) Researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phlegm-Blood Stasis Syndrome scoring criteria;Seattle Angina Scale score;Coronary Heart Disease Clinical Symptom Grading Scale; | — |
Countries
China
Contacts
Public ContactHe Qingyong
Guang-An-Men Hospital, Chinese Academy of Chinese Medical Sciences
Outcome results
None listed